8-K: My Size Inc. Secures $3.26 Million Through Warrant Exercise and Issues New Warrants

My Size, Inc. has entered into an agreement with a warrant holder to exercise existing warrants at a reduced price, generating approximately $3.26 million in gross proceeds and issuing new warrants.

Summary

• My Size, Inc. has entered into an inducement offer letter agreement with a holder of existing warrants.
• The holder agreed to exercise warrants for 670,989 shares at a reduced price of $4.86 per share, down from the original $16.72.
• In exchange, My Size will issue new warrants to purchase up to 1,341,978 shares at an exercise price of $4.61 per share.
• The company expects to receive gross proceeds of approximately $3.26 million from the exercise of the existing warrants.
• H.C. Wainwright & Co., LLC is acting as the placement agent and will receive a cash fee of 7% of the gross proceeds, plus a 1% management fee.
• The placement agent will also receive warrants to purchase 46,969 shares at an exercise price of $6.075 per share.
• The closing of the transaction is expected to occur on or about May 20, 2024.
• The net proceeds from the transaction will be used for general corporate purposes.
• The company has agreed not to issue any shares of common stock or equivalents for 45 days after the closing date, with some exceptions.
• The company has also agreed not to effect any variable rate transactions for one year after the closing date, with some exceptions.

Sentiment

Score: 6

Explanation: The document indicates a necessary capital raise, which is positive for the company's immediate financial needs, but the dilution and restrictions on future financing are a concern. The sentiment is neutral to slightly positive.

Positives

• The company is raising $3.26 million in gross proceeds, which will be used for general corporate purposes.
• The warrant exercise provides immediate capital to the company.
• The reduced exercise price may encourage further warrant exercises in the future.
• The company has secured a placement agent to assist with the transaction.

Negatives

• The company is issuing a significant number of new warrants, which could dilute existing shareholders.
• The placement agent fees and expenses will reduce the net proceeds received by the company.
• The company is subject to restrictions on future equity issuances and variable rate transactions for a specified period.

Risks

• The closing of the transaction is subject to customary closing conditions and may not occur as expected.
• The company may not be able to effectively use the net proceeds for general corporate purposes.
• The new warrants may not be exercised, resulting in less capital for the company.
• The company's share price could be negatively impacted by the issuance of new warrants and shares.
• The lack of a trading market for the new warrants could limit their liquidity.

Future Outlook

The company expects to use the net proceeds from these transactions for general corporate purposes and has agreed to certain restrictions on future equity issuances and variable rate transactions.

Management Comments

• The company is pleased to offer the opportunity to receive new warrants and a reduction in the exercise price of existing warrants.
• The company desires to reduce the exercise price of the existing warrants to $4.86 per share.

Industry Context

This type of transaction is common for companies seeking to raise capital, particularly those with existing warrants. The use of a placement agent is also a standard practice in such financings.

Comparison to Industry Standards

• The warrant inducement structure is a common method for companies to raise capital, particularly for smaller cap companies.
• The fees paid to the placement agent are within the typical range for such transactions.
• The restrictions on future equity issuances and variable rate transactions are also common in these types of agreements to protect the investors.
• The reduced exercise price of $4.86 per share is a significant discount from the original $16.72, which is a common incentive to encourage warrant holders to exercise their options.
• The new warrants have an exercise price of $4.61, which is slightly lower than the reduced exercise price of the existing warrants, which is a common practice to incentivize the warrant holder.

Stakeholder Impact

• Shareholders will experience dilution due to the issuance of new shares and warrants.
• The company will have additional capital to fund operations.
• The placement agent will receive fees and warrants for their services.

Next Steps

• The company will close the transaction on or about May 20, 2024.
• The company will file a registration statement for the resale of the new warrant shares.
• The company will use the net proceeds for general corporate purposes.

Key Dates

Keywords

warrants, capital raise, equity financing, placement agent, common stock, inducement offer, exercise price, dilution